Recombinant alzheimer's amyloid protein

Details Recombinant alzheimer's amyloid protein Recombinant alzheimer's amyloid protein

A - Human Necessities

61

K

530/7.1, 195/1.2

A61K 38/55 (2006.01)

Patent

CA 1341004

DNA sequences encoding the .beta.-amyloid core protein, and .beta.-amyloid-related proteins associated with Alzheimer's disease are disclosed. These sequences are used in producing or constructing recombinant .beta.-amyloid core protein, .beta.3-amyloid-related proteins and recombinant or synthetic immunogenic peptides. These sequences are also used to identify genomic mutations and/or restriction site alterations which are associated with a predisposition to Alzheimer's disease, for purposes of genetic screening. Antibodies generated against the recombinant proteins or immunogenic peptides derived therefrom can be used for cerebral fluid or serum protein diagnosis of Alzheimer's disease.

551702

Affiliated with

Also associated with

Rating

Recombinant alzheimer's amyloid protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant alzheimer's amyloid protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant alzheimer's amyloid protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1268376